Knowledge Center
Article / Jan 01, 2011
What is Special About Inhalation APIs?
Source:
Drug Development and Delivery, January 2011
What is Special About Inhalation APIs? Drug Development Executive: Carla Vozone, Director of Business Development for Hovione's Generics Business Unit, discusses what makes Hovione unique in API supply for inhalation, its supportive technologies, and approach to the market.
Related links
Also in the Knowledge Center
Scientific Article
/ Oct 15, 2017
In vitro - in vivo Correlations of Carbamazepine Nanodispersions for Application in Formulation Development
Read more
Scientific Article
/ Nov 12, 2017
Use of Supercritical-CO2 Assisted Spray Drying for the production of Pharmaceutical compounds
Read more
Scientific Article